Recent Press Releases

PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting

INDIANAPOLIS, May 28, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced final results of

Lilly to Present CYRAMZA® (ramucirumab) Data at 2015 ASCO Annual Meeting

INDIANAPOLIS, May 28, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that data from se

Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data

INDIANAPOLIS, May 28, 2015  /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (Na

Amgen Launches Program To Further Advance Basic Biology Research

More Than 1,000 Tools and Resources Made Available to Academic Institutions Including Small Molecules, Peptides, Antibodies and Recombinant Proteins, Engineered Cell Lines, and Genetically-Enginee

Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults LAVAL, Quebec, May 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International,...

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

-First in class treatment for IBS-D treats hallmark symptoms of IBS-D; abdominal pain and diarrhea - IBS-D can be debilitating, affecting up to 15 million Americans, and there are limited...

Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis

NEW BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the acceptance of the March 1, 2015 binding offer from Cardinal Health to acquire its Cordis...

AMAG Pharmaceuticals Receives Complete Response Letter From FDA for the Single-Dose Vial of Makena(R)

Company Affirms 2015 Financial Outlook WALTHAM, Mass., May 28, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), today announced that it has received a complete response letter...

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals NIH-funded trial results likely will impact global treatment guidelines For Immediate Release: Wednesday, May...

Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's 75th Scientific Sessions®

Clinical and pre-clinical data on compounds representing several of the largest diabetes treatment classes will be presented

RIDGEFIELD,

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®

Marks approval of first concentrated mealtime insulin analog in the U.S.

Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

SAN DIEGO, May 27, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European Hematology Association (EHA)

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present

Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions

Range of abstracts reflects Lilly Diabetes' comprehensive portfolio

INDIANAPOLIS, May 27, 2015 /PRNe

Amgen To Present At The Jefferies 2015 Global Healthcare Conference

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Jefferies 2

Bayer has outstanding perspectives as a pure Life Science company

Very successful fiscal 2014 both strategically and operationally / Dividend increase to EUR 2.25 per share for 2014 proposed / Employees share in the company's success through total bonuses of...

Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA

EAST HANOVER, N.J., May 27, 2015 -- Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at...

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR

DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014...